HBV genotyping and drug-resistance assay portfolio from Genient Technologies, including DeepChek RT and whole-genome HBV sequencing workflows.
Genient Technologies supports hepatitis B virus sequencing workflows with assay options for HBV genotyping and drug-resistance research. These solutions help laboratories evaluate relevant HBV genomic regions through PCR amplification, sequencing, and downstream analysis support.
The portfolio includes focused reverse-transcriptase genotyping and whole-genome HBV sequencing options for laboratories that need deeper insight into viral genotype and resistance-associated markers.
Choose a focused RT assay for resistance workflows or a broader whole-genome option when expanded HBV sequence coverage is required.
A research-use HBV assay workflow for amplifying relevant reverse-transcriptase gene regions from extracted plasma or serum DNA.
View Details
A whole-genome HBV genotyping page for laboratories looking to extend beyond focused RT-region sequencing.
View Details
Our team can help map target region, sequencing platform, sample pathway, and reporting need to a practical genotyping solution.
Talk To Us
Designed for molecular laboratories that need reliable assay options across amplification, sequencing, analysis, and reporting touchpoints.
Select RT-region coverage for drug-resistance work or whole-genome coverage for expanded HBV genotyping needs.
PCR-based assay options are aligned to sequencing and downstream interpretation workflows used in molecular laboratories.
DeepChek HBV software/module support helps structure interpretation and reporting around HBV sequencing data.
Speak with Genient Technologies for assay selection, availability, and implementation support.
Contact Us